Tandlæge Susanne Junge ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 2.6% 2.1%  
Credit score (0-100)  0 0 0 61 65  
Credit rating  N/A N/A N/A BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 4,843 7,292  
EBITDA  0.0 0.0 0.0 1,301 1,191  
EBIT  0.0 0.0 0.0 780 730  
Pre-tax profit (PTP)  0.0 0.0 0.0 561.9 342.9  
Net earnings  0.0 0.0 0.0 438.9 266.4  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 562 343  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 1,475 1,546  
Shareholders equity total  0.0 0.0 0.0 479 628  
Interest-bearing liabilities  0.0 0.0 0.0 12,184 5,158  
Balance sheet total (assets)  0.0 0.0 0.0 7,220 6,808  

Net Debt  0.0 0.0 0.0 11,893 5,058  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 4,843 7,292  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 50.6%  
Employees  0 0 0 7 10  
Employee growth %  0.0% 0.0% 0.0% 0.0% 42.9%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 7,220 6,808  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% -5.7%  
Added value  0.0 0.0 0.0 780.4 1,191.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 5,895 -651  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 2.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 16.1% 10.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 10.9% 10.4%  
ROI %  0.0% 0.0% 0.0% 10.8% 11.0%  
ROE %  0.0% 0.0% 0.0% 91.6% 48.1%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 0.0% 6.6% 9.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 914.4% 424.6%  
Gearing %  0.0% 0.0% 0.0% 2,543.9% 821.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 3.7% 4.5%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.6 0.3  
Current Ratio  0.0 0.0 0.0 0.7 0.4  
Cash and cash equivalent  0.0 0.0 0.0 290.4 99.8  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -392.8 -832.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 111 119  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 186 119  
EBIT / employee  0 0 0 111 73  
Net earnings / employee  0 0 0 63 27